dihydroergotamine 5.2 MG Nasal Powder
RxNorm concept 2714187, clinical drug (scd).
- RxCUI
- 2714187
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2714187 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
DHE 5.2 MG Nasal Powder; dihydroergotamine 5.2 MG (equivalent to dihydroergotamine mesylate 6 MG) Nasal Powder
Related concepts
- dihydroergotamine 5.2 MG (SCDC, consists of)
- Nasal Powder (DF, has dose form)
- dihydroergotamine 5.2 MG Nasal Powder [Atzumi] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2714187 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2714187 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2714187. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.